Alain Leibman was quoted in the Indianapolis Business Journal article, "Feds Drop Case against Former Lilly Scientists Accused of Stealing Secrets." Full text can be found in the December 5, 2014, issue, but a synopsis is below.
Federal prosecutors dropped all charges against two former Eli Lilly scientists accused of stealing trade secrets worth $55 million according to a court motion made Friday.
Defense attorney Alain Leibman explained that the additional information was "a fundamental shift by Lilly indicating that information originally alleged to be confidential and proprietary was actually not confidential and proprietary."
Leibman said Li admitted no wrongdoing in his interview with the FBI. Leibman also claimed none of the information exchanged by email between Cao and Li was confidential or proprietary but was being discussed widely by scientists at most pharmaceutical companies.
"Lilly provided bad information to the government," stated Leibman, who represents Cao in the case.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.